February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

20 mg/mL, 2 mL vial (NDC 63323-0495-27) 20 mg/mL, 5 mL vial (NDC 63323-0495-07) 20 mg/mL, 10 mL ampule (NDC 63323-0496-97) Lidocaine 2% injection, Hospira 20 mg/mL, 2 mL glass ampule, preservative- -free (NDC 00409-4282-01) 20 mg/mL, 5 mL vial, preservative-free (NDC 00409-2066-05) 20 mg/mL, 20 mL vial (NDC 00409-4277-01) 20 mg/mL, 50 mL vial (NDC 00409-4277-02) 20 mg/mL, 10 mL glass ampule, preservative-free (NDC 00409-4282-02) Reason for the Shortage Hospira has lidocaine 1% and 2% presentations on shortage due to manufacturing delays. APP has Xylocaine and lidocaine presentations on shortage due to increased demand for the product. Lidocaine emergency syringes are not affected by this shortage. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=859 Source: http://www.a ashp.org Lidocaine with Epinephrine Injection January 25, 2012 Products Affected - Description Lidocaine 0.5% with epinephrinee Xylocaine 0.5% (with epinephrine 1:200,0000 injection), APP 5 mg/mL, 50 mL vial (NDC 63323-0481-57) Lidocaine 0.5% (with epinephrine 1:200,0000 injection), Hospira 5 mg/mL, 50 mL vial (NDC 00409-3177-01) Lidocaine 1% with epinephrine Xylocaine 1% (with epinephrine 1:200,000 injection), APP 10 mg/mL, 10 mL vial (NDC 63323-0482-17) 10 mg/mL, 20 mL vial (NDC 63323-0482-27) 10 mg/mL, 50 mL vial (NDC 63323-0482-57) Xylocaine 1% - MPF (with epinephrine 1:200,000 injection), APP 10 mg/mL, 10 mL vial (NDC 63323-0487-17) 10 mg/mL, 30 mL vial (NDC 63323-0487-37) 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0487-31) Lidocaine 1% (with epinephrine 1:100,000) injection, Hospira 10 mg/mL, 50 mL vial (NDC 00409-3178-03) Lidocaine 1.5% with epinephrinee Xylocaine 1.5% - MPF (with epinephrine 1:200,000 injection), APP 15 mg/mL, 10 mL vial (NDC 63323-0488-17) 15 mg/mL, 30 mL vial (NDC 63323-0488-37) Lidocaine 1.5% (with epinephrine 1:200,0000 injection), Hospira 15 mg/mL, 5 mL glass ampule, 100 count (NDC 00409-1209-65) Lidocaine 2% with epinephrine Xylocaine 2% (with epinephrine 1:200,000 injection), APP 20 mg/mL, 20 mL vial (NDC 63323-0483-27) 20 mg/mL, 50 mL vial (NDC 63323-0483-57) Xylocaine 2% - MPF (with epinephrine 1:200,000 injection), APP 20 mg/mL, 10 mL vial (NDC 63323-0489-17) 20 mg/mL, 20 mL vial (NDC 63323-0489-27) 20 mg/mL, 20 mL vial, sterile pack (NDC 63323-0489-21) 32
Lidocaine 2% (with epinephrine 1:100,000 injection), Hospira 20 mg/mL, 20 mL vial (NDC 00409-3182-01) 20 mg/mL, 30 mL vial (NDC 00409-3182-02) 20 mg/mL, 50 mL vial (NDC 00409-3182-03) Reason for the Shortage Hospira has lidocaine with epinephrine presentations on shortage due to manufacturing delays. APP has Xylocaine with epinephrine presentations on shortage due to increased demand for the product. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=860 Source: http://www.a ashp.org Atropine Sulfate Injection January 27, 2012 Products Affected - Description Atropine injection, Hospira 0.05 mg/ /mL, 5 mL Ansyr syringe, package of 10 (NDC 00409-9630-05) Atropine injection, American Regent 0.4 mg/mL, 0.5 mL ampule, package of 25 (NDC 00517-0805-25) 0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25) 1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25) 1 mg/mL, 1 mL ampule, package of 25 (NDC 00517-0101-25) Atropine injection, West-Ward (formerly Baxter) 0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 10019-0250-12) 0.4 mg/mL, 20 mL multi-dose vial, package of 10 (NDC 10019-0250-20) 1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 10019-0251-12) Reason for the Shortage American Regent had temporarily suspendedd manufacture of most drug products in April, 2011. American Regent resumed manufacturing in Shirley, New York in early-May, 2011. Hospira states the shortage is due to manufacturing delays. West-Ward could not provide a reason for the shortage. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=814 Source: http://www.a ashp.org Calcium Chloride Injection January 27, 2012 Products Affected - Description Calcium Chloride 100 mg/mL Injection, Hospira 100 mg/mL, 10 mL Ansyr syringe (NDC 00409-1631-10) 100 mg/mL, 10 mL LifeShield syringe (NDC 00409-4928-34) Reason for the Shortage American Regent had temporarily suspendedd distributionn of most drug products including calcium chloride in April, 2011. American Regent resumed manufacturing in Shirley, New York in early-May, 2011. Hospira has calcium chloride on shortage due to manufacturing delays. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=657 Source: http://www.a ashp.org Cilostazol Tablets January 27, 2012 Products Affected - Description 33
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13 and 14: acteria. The Food and Drug Administ
Page 15 and 16: Statins raise risk of Type 2 diabet
Page 17 and 18: The Million Women Study, a U.K. pro
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23 and 24: Recalling Firm: Pfizer Us Pharmaceu
Page 25 and 26: 250 mg, 100 count (NDC 00591-3969-0
Page 27 and 28: Sandoz states the shortage is due t
Page 29 and 30: 5 mL ampule (NDC 10019-0033-72) 20
Page 31: Article Link: http://www.ashp.org/D
Page 35 and 36: Source: http://www.a ashp.org Halop
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45 and 46: Bedford Laboratories has multiple p
Page 47 and 48: Thiothixene capsules, Mylan 2 mg ca
Page 49 and 50: 20 mL vials (NDC 10019-0905-03) - d
Page 51 and 52: 500 mg extended release, 500 count
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?